VANESSA ENRIQUEZ: Open Payments
NPI 1649731415 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$622 in 34 payments from 13 companies in 2025. Trend: 2023 $869 · 2024 $667 · 2025 $622
Food & beverage: $622
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $223 |
| Gilead Sciences, Inc. | 6 | $102 |
| Novo Nordisk Inc | 4 | $71 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Lilly USA, LLC | 2 | $30 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Hologic Sales and Service, LLC | 1 | $25 |
| Astellas Pharma US Inc | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| Exact Sciences Corporation | 1 | $19 |
Products named: QULIPTA, VRAYLAR, MAVYRET, UBRELVY, Rybelsus, AIRSUPRA, MOUNJARO, TRELEGY ELLIPTA.
Industry payments across FL — which companies pay providers there.
